Diabetes drug Ozempic, which has become popular for its role in weight loss, may cause a rare risk of vision loss, research suggests.
According to BloombergA recent non-peer-reviewed study revealed a link between Novo Nordisk’s Ozempic and a rare eye condition called non-arterial anterior ischemic optic neuropathy (NAION). , which can eventually cause vision loss.
Researchers analyzed patient data from Denmark and Norway and found that Ozempic users were twice as likely to develop NAION as people taking other diabetes medications.
However, the study emphasizes that the overall risk of NAION remains extremely low. The estimated additional risk for type 2 diabetics taking Ozempic for 20 years is only 0.3% to 0.5%.
According to Quartz However, the findings of Wegovy, the weight loss pill that shares Ozempic’s active ingredient, are inconclusive due to limited data. The study emphasizes the importance of monitoring for potential side effects. NAION is a serious eye condition that affects the optic nerve, leading to sudden and irreversible loss of vision. Although rare, it is important to weigh the potential risks of NAION against the significant benefits of semaglutide in controlling diabetes and obesity.
Wegovy has been approved for weight management in obese adults and children 12 years of age and older. Ozempic is approved to lower blood sugar when you have type 2 diabetes.
Ozempic is known as “Hollywood’s best-kept secret” and became incredibly popular thanks to TikTok as a quick weight loss solution, especially among young women.